Sanofi India Ltd

Sanofi India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi India Ltd

₹ 6,162 0.85%
20 Dec - close price
sanofiindialtd.com BSE: 500674 NSE: SANOFI
About

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

Key Points

Parent Company[1]
Sanofi Global and its 100% subsidiary - Hoechst GmbH, are the shareholders of Sanofi India and together hold 60.40%. Company's follows parent company's financial year hence, Financial year is same as Calender Year.

Website BSE NSE
  • Market Cap ₹ 14,191 Cr.
  • Current Price ₹ 6,162
  • High / Low ₹ 7,600 / 4,606
  • Stock P/E 33.7
  • Book Value ₹ 298
  • Dividend Yield 2.71 %
  • ROCE 71.1 %
  • ROE 51.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
  • Company has been maintaining a healthy dividend payout of 131%

Cons

  • Stock is trading at 20.7 times its book value
  • The company has delivered a poor sales growth of 0.57% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Part of Nifty MidSmall Healthcare Nifty Total Market Nifty 500 Multicap 50:25:25 Nifty Smallcap 250 BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
754 688 707 699 692 672 736 515 491 694 511 464 524
556 561 512 538 510 505 507 393 377 506 374 348 404
Operating Profit 199 127 194 161 182 167 230 122 114 187 137 116 120
OPM % 26% 18% 28% 23% 26% 25% 31% 24% 23% 27% 27% 25% 23%
504 16 142 16 11 34 44 57 82 12 41 21 2
Interest 0 0 0 0 0 0 0 1 0 0 0 0 0
Depreciation 14 11 11 11 10 10 10 9 9 10 9 9 9
Profit before tax 688 132 326 166 182 190 264 169 186 189 169 127 113
Tax % 23% 32% 27% 27% 28% 31% 28% 27% 18% 27% 19% 19% 27%
530 90 238 120 131 131 190 123 152 138 137 103 82
EPS in Rs 230.35 39.30 103.65 52.35 56.91 56.91 82.78 53.43 66.17 59.87 59.39 44.96 35.74
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 TTM
1,573 1,809 1,977 2,193 2,367 2,460 2,771 3,071 2,902 2,957 2,770 2,851 2,192
1,261 1,411 1,639 1,817 1,832 1,921 2,146 2,403 2,186 2,194 2,066 2,047 1,632
Operating Profit 312 398 339 376 535 538 625 667 716 762 704 804 560
OPM % 20% 22% 17% 17% 23% 22% 23% 22% 25% 26% 25% 28% 26%
41 83 131 218 66 79 88 33 45 564 204 83 77
Interest 1 0 0 0 2 1 1 0 2 2 2 2 2
Depreciation 90 92 97 113 119 102 103 100 82 67 42 40 37
Profit before tax 262 388 373 481 480 515 610 600 677 1,258 864 846 598
Tax % 32% 32% 29% 33% 37% 37% 38% 31% 29% 25% 28% 29%
177 265 264 322 304 326 381 414 478 944 621 603 460
EPS in Rs 76.81 115.30 114.61 139.78 132.26 141.74 165.48 180.09 207.65 410.61 269.83 262.26 199.96
Dividend Payout % 43% 39% 39% 46% 51% 50% 51% 194% 176% 119% 211% 64%
Compounded Sales Growth
10 Years: 5%
5 Years: 1%
3 Years: -1%
TTM: -9%
Compounded Profit Growth
10 Years: 9%
5 Years: 9%
3 Years: 5%
TTM: -9%
Stock Price CAGR
10 Years: 11%
5 Years: 8%
3 Years: 9%
1 Year: 25%
Return on Equity
10 Years: 22%
5 Years: 27%
3 Years: 33%
Last Year: 52%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Jun 2024
Equity Capital 23 23 23 23 23 23 23 23 23 23 23 23 23
Reserves 1,181 1,324 1,463 1,604 1,860 2,003 2,196 2,419 2,096 2,203 1,253 992 662
0 0 0 0 0 0 0 0 23 25 24 19 22
427 532 742 778 658 751 765 802 777 811 772 681 654
Total Liabilities 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,360
699 699 648 877 817 769 733 499 464 334 306 315 302
CWIP 43 136 210 22 34 30 21 17 10 13 24 16 29
Investments 0 0 0 0 0 0 0 0 0 0 0 2 0
888 1,043 1,369 1,505 1,690 1,978 2,230 2,728 2,444 2,714 1,743 1,382 1,029
Total Assets 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,360

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
290 273 265 213 322 435 374 412 611 559 399 231
-5 -335 61 36 -155 -79 -73 66 276 631 651 36
-90 -105 -122 -147 -180 -188 -197 -183 -810 -849 -1,583 -878
Net Cash Flow 195 -168 205 102 -13 168 104 295 78 341 -533 -612

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Debtor Days 23 24 21 24 22 29 21 27 19 18 17 17
Inventory Days 135 151 179 173 169 151 154 127 107 110 125 202
Days Payable 75 83 122 81 79 119 110 100 93 105 109 89
Cash Conversion Cycle 83 92 78 115 112 61 65 54 33 22 33 130
Working Capital Days 3 43 26 9 79 17 18 35 -7 -19 -18 25
ROCE % 23% 29% 22% 26% 27% 26% 29% 28% 32% 35% 41% 71%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
9.22% 8.99% 8.71% 8.26% 6.99% 6.71% 6.72% 6.80% 6.31% 6.11% 5.81% 5.78%
19.05% 18.65% 18.59% 18.28% 19.22% 19.46% 19.65% 21.68% 22.51% 22.88% 22.60% 22.62%
11.33% 11.96% 12.30% 13.08% 13.41% 13.43% 13.22% 11.10% 10.78% 10.61% 11.21% 11.20%
No. of Shareholders 50,91659,27664,54273,73474,59376,69471,51368,59862,87061,84967,66266,211

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls